Surgical formation of an opening through the ABDOMINAL WALL into the JEJUNUM, usually for enteral hyperalimentation.
Nutritional support given via the alimentary canal or any route connected to the gastrointestinal system (i.e., the enteral route). This includes oral feeding, sip feeding, and tube feeding using nasogastric, gastrostomy, and jejunostomy tubes.
The insertion of a tube into the stomach, intestines, or other portion of the gastrointestinal tract to allow for the passage of food products, etc.
Creation of an artificial external opening into the stomach for nutritional support or gastrointestinal compression.
A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.
Methods of giving food to humans or animals.
Abnormal passage between the ESOPHAGUS and the TRACHEA, acquired or congenital, often associated with ESOPHAGEAL ATRESIA.
Intractable VOMITING that develops in early PREGNANCY and persists. This can lead to DEHYDRATION and WEIGHT LOSS.
The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum.
Excision of part (partial) or all (total) of the esophagus. (Dorland, 28th ed)
Abnormal passage communicating with the ESOPHAGUS. The most common type is TRACHEOESOPHAGEAL FISTULA between the esophagus and the TRACHEA.
The administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered by a route other than the alimentary canal (e.g., intravenously, subcutaneously).
General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients.
Excision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 28th ed)
The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed)

Peripheral hepatojejunostomy as palliative treatment for irresectable malignant tumors of the liver hilum. (1/170)

OBJECTIVE: To evaluate the concept of surgical decompression of the biliary tree by peripheral hepatojejunostomy for palliative treatment of jaundice in patients with irresectable malignant tumors of the liver hilum. SUMMARY BACKGROUND DATA: Jaundice, pruritus, and recurrent cholangitis are major clinical complications in patients with obstructive cholestasis resulting from malignant tumors of the liver hilum. Methods for palliative treatment include endoscopic stenting, percutaneous transhepatic drainage, and surgical decompression. The palliative treatment of choice should be safe, effective, and comfortable for the patient. METHODS: In a retrospective study, surgical technique, perioperative complications, and efficacy of treatment were analyzed for 56 patients who had received a peripheral hepatojejunostomy between 1982 and 1997. Laparotomy in all of these patients had been performed as an attempt for curative resection. RESULTS: Hepatojejunostomy was exclusively palliative in 50 patients and was used for bridging to resection or transplantation in 7. Anastomosis was bilateral in 36 patients and unilateral in 20. The 1-month mortality in the study group was 9%; median survival was 6 months. In patients surviving >1 month, a marked and persistent decrease in cholestasis was achieved in 87%, although complete return to normal was rare. Among the patients with a marked decrease in cholestasis, 72% had no or only mild clinical symptoms such as fever or jaundice. CONCLUSIONS: Peripheral hepatojejunostomy is a feasible and reasonably effective palliative treatment for patients with irresectable tumors of the liver hilum. In patients undergoing exploratory laparotomy for attempted curative resection, this procedure frequently leads to persistent-although rarely complete-decompression of the biliary tree. In a few cases it may also be used for bridging to transplantation or liver resection after relief of cholestasis.  (+info)

Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure. (2/170)

BACKGROUND: Glucagon-like peptide 2 (GLP-2) is a growth factor for the intestinal epithelium in rodents and may affect intestinal transit. AIMS: To study the GLP-2 response to nutrient ingestion in seven short bowel patients with intestinal failure and seven controls. METHODS: The patients and controls were admitted twice for two test meals after a night of fasting. Meal A was liquid (300 ml, 1.88 MJ); meal B was a regular breakfast (755 g, 3.92 MJ). Plasma samples were collected for 180 minutes; GLP-2 immunoreactivity was measured with an NH(2) terminal specific radioimmunoassay. RESULTS: Both meals elicited significant increases in plasma GLP-2 in controls. The magnitude and duration of the responses were dependent on the meal size: the maximum median (25-75%) increases after meal A and B were 24 (3-28) and 48 (33-56) pmol/l. Plasma GLP-2 returned to basal concentrations 180 minutes after meal A, but remained at 50% of peak values after meal B. In the patients neither meal significantly changed the GLP-2 concentration; the maximum median elevation after meal B was 5 (2-8) pmol/l. There were significant differences between patients and controls with respect to the GLP-2 responses to meals A and B. CONCLUSION: Identification of GLP-2 as a tissue specific intestinal growth factor and demonstration of an impaired meal stimulated GLP-2 response in short bowel patients raises the possibility that GLP-2 administration may constitute a new therapeutic strategy, enhancing jejunal adaptation in ileum resected short bowel patients with intestinal failure.  (+info)

Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. (3/170)

OBJECTIVE: This prospective, randomized, single-institution trial was designed to evaluate the role of prophylactic gastrojejunostomy in patients found at exploratory laparotomy to have unresectable periampullary carcinoma. SUMMARY BACKGROUND DATA: Between 25% and 75% of patients with periampullary cancer who undergo exploratory surgery with intent to perform a pancreaticoduodenectomy are found to have unresectable disease. Most will undergo a biliary-enteric bypass. Whether or not to perform a prophylactic gastrojejunostomy remains unresolved. Retrospective reviews of surgical series and prospective randomized trials of endoscopic palliation have demonstrated that late gastric outlet obstruction, requiring a gastrojejunostomy, develops in 10% to 20% of patients with unresectable periampullary cancer. METHODS: Between May 1994 and October 1998, 194 patients with a periampullary malignancy underwent exploratory surgery with the purpose of performing a pancreaticoduodenectomy and were found to have unresectable disease. On the basis of preoperative symptoms, radiologic studies, or surgical findings, the surgeon determined that gastric outlet obstruction was a significant risk in 107 and performed a gastrojejunostomy. The remaining 87 patients were thought by the surgeon not to be at significant risk for duodenal obstruction and were randomized to receive either a prophylactic retrocolic gastrojejunostomy or no gastrojejunostomy. Short- and long-term outcomes were determined in all patients. RESULTS: Of the 87 patients randomized, 44 patients underwent a retrocolic gastrojejunostomy and 43 did not undergo a gastric bypass. The two groups were similar with respect to age, gender, procedure performed (excluding gastrojejunostomy), and surgical findings. There were no postoperative deaths in either group, and the postoperative morbidity rates were comparable (gastrojejunostomy 32%, no gastrojejunostomy 33%). The postoperative length of stay was 8.5+/-0.5 days for the gastrojejunostomy group and 8.0+/-0.5 days for the no gastrojejunostomy group. Mean survival among those who received a prophylactic gastrojejunostomy was 8.3 months, and during that interval gastric outlet obstruction developed in none of the 44 patients. Mean survival among those who did not have a prophylactic gastrojejunostomy was 8.3 months. In 8 of those 43 patients (19%), late gastric outlet obstruction developed, requiring therapeutic intervention (gastrojejunostomy 7 patients, endoscopic duodenal stent 1 patient; p < 0.01). The median time between initial exploration and therapeutic intervention was 2 months. CONCLUSION: The results from this prospective, randomized trial demonstrate that prophylactic gastrojejunostomy significantly decreases the incidence of late gastric outlet obstruction. The performance of a prophylactic retrocolic gastrojejunostomy at the initial surgical procedure does not increase the incidence of postoperative complications or extend the length of stay. A retrocolic gastrojejunostomy should be performed routinely when a patient is undergoing surgical palliation for unresectable periampullary carcinoma.  (+info)

Aortoesophageal fistula caused by aneurysm of the thoracic aorta: successful surgical treatment, case report, and literature review. (4/170)

Aortoesophageal fistula induced by atherosclerotic thoracic aortic aneurysm is rare, but is usually a fatal disorder, with few survivors reported. We report the case of a 72-year-old man with aortoesophageal fistula successfully treated in a two-stage operation. In the first stage, we performed resection and replacement of the aortic aneurysm with a prosthetic graft in situ, esophagectomy, cervical esophagostomy, and jejunostomy. After the patient recovered well postoperatively, a transmediastinal retrosternal interposition of the stomach was performed, with esophagogastroanastomosis in the cervical area, to re-establish the gastrointestinal tract. We include a discussion of the causes, diagnostic approach, management of the aorta and esophagus, and review of the literature.  (+info)

Pancreatic injury: an audit and a practical approach. (5/170)

Pancreatic injuries are uncommon, difficult to diagnose and there is no uniform standard for treatment. The purpose of this study was to audit the management of pancreatic injuries in our practice. Equally important is to attempt to find out a simple management plan particularly in the era of increasing conservative treatment of injured patients. There were 22 cases of pancreatic injury. The average Glasgow coma scale of 10.9 and injury severity score of 29.1. When computed tomography is used it has a sensitivity of 33.3% which became 100% if repeated or other injuries were identified. There was one case in grade I which was treated non-operatively. There were 15 patients in grade II and they were treated by drainage. Distal pancreatectomy and splenectomy was the treatment of 3 patients with grade III injury. One patient had pancreatico-jejunostomy for grade IV injury and subsequently developed pancreatic fistula. Pancreaticoduodenectomy was the treatment of choice for two patients with grade V and both subsequently died. The over all mortality of this series was 22.7% and intra-abdominal abscesses noted in 9.1%. This series indicated that there is a need to adopt 'bail out' procedures particularly in grade IV and V pancreatic injury. A simplified management plan is suggested.  (+info)

A novel approach in treating recurrent bilateral hepaticojejunostomy biliary strictures post-liver transplantation: Successful use of Simpson's atherectomy device. (6/170)

Biliary complications occur in 6% to 34% of patients who undergo orthotopic liver transplantation. Strictures at the anastomosis site or elsewhere in the biliary tract are common. These strictures are amenable to interventional radiological and surgical procedures; however, retransplantation is sometimes an inevitable outcome. An 8-year-old boy received combined liver and kidney transplants May 31, 1998. Hepatic artery thrombosis was diagnosed postoperative day 1 and treated with revascularization. The choledochojejunostomy was revised twice and resulted in a high hepaticojejunostomy. Significant strictures on both the right and left hepatic ducts at the anastomosis site were unsuccessfully treated by multiple interventional radiological procedures. The option of retransplantation was seriously explored. Simpson's atherectomy device was used in a novel approach February 24, 1999, and strictures on both ducts were successfully treated. At 1-year postprocedure, the patient has normal liver function with no evidence of recurrence of the strictures. Further experience with this novel technique is required to assess its role in treating biliary strictures post liver transplantation.  (+info)

Expression of cyclin D1 and p53 and its correlation with proliferative activity in the spectrum of esophageal carcinomas induced after duodenal content reflux and 2,6-dimethylnitrosomorpholine administration in rats. (7/170)

Alterations in expression of the p53 and cyclin D1 genes have been implicated in the development of esophageal carcinomas in both humans and animal models. We hypothesize that altered expression of cyclin D1 and p53 may be involved in the sequential development of esophageal carcinomas with glandular differentiation induced by the carcinogen, 2,6-dimethylnitrosomorpholine (DMNM) in rats with duodenal content reflux esophagitis. In the present study Sprague-Dawley rats were given DMNM 15 days after performing an esophago-jejunostomy in order to induce chronic duodenal content reflux esophagitis. Expression and localization of p53, cyclin D1 and Ki-67 were examined by immunohistochemical analyses. Twenty of 24 animals developed different types of esophageal carcinomas, including pure squamous carcinoma, adenosquamous carcinoma and pure adenocarcinoma. Undifferentiated basaloid areas were frequently observed in these tumors. Cyclin D1 overexpression was observed in hyperplastic lesions and increased through dysplasia and in undifferentiated areas of infiltrating carcinoma. Cyclin D1 expression coincided with increased Ki-67 expression and decreased along with cell differentiation. The p53 immunohistochemical pattern was parallel to that of cyclin D1, although the percentage of positive cells was usually smaller in all lesions and increased p53 expression started at the dysplastic stage. These findings suggest that overexpression of cyclin D1 may be an early event in DMNM-induced rat esophageal tumorigenesis, causing increased proliferation of esophageal stem cells. Abnormal p53 expression may then be required to promote the development of neoplastic transformation from dysplastic epithelium through invasive phenotype, being more evident in cancer cells with squamous differentiation.  (+info)

Pancreatic transplantation and subsequent graft surveillance by pancreatic portal-enteric anastomosis and temporary venting jejunostomy. (8/170)

OBJECTIVE: To evaluate portal-enteric (PE) pancreas and kidney transplantation with venting jejunostomy (VJ) for its efficacy, safety, and reproducibility. SUMMARY BACKGROUND DATA: Simultaneous pancreas and kidney transplantation for patients with long-standing insulin-dependent diabetes mellitus that progresses to renal failure has revolutionized their treatment and quality of life. A current clinical focus is to refine the technical aspects of this procedure. Simultaneous pancreas and kidney transplantation with PE anastomosis with VJ appears to offer several advantages over bladder drainage. VJ allows initial decompression of the enteric anastomosis, monitoring of pancreatic function by ostomy amylase, and simple access for endoscopic evaluation and biopsy of the allograft. METHODS: Simultaneous pancreas and kidney transplantation with VJ was performed in 21 patients from December 1996 to October 2000 at Willis Knighton/LSU Regional Transplant Center. All patients had long-standing insulin-dependent diabetes mellitus and subsequent renal failure. They were evaluated at the time of surgery by a multidisciplinary transplant team and monitored for numerous factors, including length of hospital stay, immunosuppressive regimen, and ischemia times. All patients had intermittent visual and biochemical evaluation of pancreatic secretions monitored by means of the VJ. RESULTS: Of the 21 patients, 10 were women and 11 were men. Four patients were black and 17 were white. The mean age at transplantation was 38 years; average human leukocyte antigen (HLA) match was one; and average cold ischemia time was 12 hours. The median hospital stay was 16 days. Four episodes of postoperative bleeding requiring exploration occurred in four patients. Postoperative wound infections developed in four patients. There were 12 episodes of rejection in nine patients. All patients with suspected acute pancreatic rejection underwent endoscopy by means of the VJ and duodenal biopsy for evaluation. Two patients lost pancreatic function subsequent to kidney failure, one secondary to noncompliance and the other as a result of hemolytic-uremic syndrome. Patient, kidney, and pancreatic survival rates were 100%, 90%, and 90%, respectively. The mean follow-up period was 25 (range 2-48) months. CONCLUSION: The authors believe that PE pancreatic drainage with VJ is a more physiologic method to perform pancreatic transplantation than bladder drainage. PE drainage allows rapid diagnosis of acute rejection and anastomotic leak and provides a simple way to monitor ostomy amylase and transplant duodenal bleeding. This technique is safe and has minimal associated complications.  (+info)

A jejunostomy is a surgical procedure where an opening (stoma) is created in the lower part of the small intestine, called the jejunum. This stoma allows for the passage of nutrients and digestive enzymes from the small intestine into a tube or external pouch, bypassing the mouth, esophagus, stomach, and upper small intestine (duodenum).

Jejunostomy is typically performed to provide enteral nutrition support in patients who are unable to consume food or liquids by mouth due to various medical conditions such as dysphagia, gastroparesis, bowel obstruction, or after certain surgical procedures. The jejunostomy tube can be used for short-term or long-term nutritional support, depending on the patient's needs and underlying medical condition.

Enteral nutrition refers to the delivery of nutrients to a person through a tube that is placed into the gastrointestinal tract, specifically into the stomach or small intestine. This type of nutrition is used when a person is unable to consume food or liquids by mouth due to various medical conditions such as swallowing difficulties, malabsorption, or gastrointestinal disorders.

Enteral nutrition can be provided through different types of feeding tubes, including nasogastric tubes, which are inserted through the nose and down into the stomach, and gastrostomy or jejunostomy tubes, which are placed directly into the stomach or small intestine through a surgical incision.

The nutrients provided through enteral nutrition may include commercially prepared formulas that contain a balance of carbohydrates, proteins, fats, vitamins, and minerals, or blenderized whole foods that are pureed and delivered through the feeding tube. The choice of formula or type of feed depends on the individual's nutritional needs, gastrointestinal function, and medical condition.

Enteral nutrition is a safe and effective way to provide nutrition support to people who are unable to meet their nutritional needs through oral intake alone. It can help prevent malnutrition, promote wound healing, improve immune function, and enhance overall health and quality of life.

I believe there might be a slight confusion in your question as intubation is a procedure typically related to the respiratory system rather than the gastrointestinal system.

Intubation generally refers to the process of inserting a tube into a specific part of the body. In the context of medical terminology, intubation usually means the placement of a flexible plastic tube through the mouth or nose and into the trachea (windpipe). This is done to secure and maintain an open airway during surgery or in emergency situations when a person cannot breathe on their own.

However, if you're referring to a procedure that involves the gastrointestinal tract, it might be "gastric lavage" or "nasogastric intubation."

Gastric lavage is a medical procedure where a tube is inserted through the mouth or nose, down the esophagus, and into the stomach to wash out its contents. This can help remove harmful substances from the stomach in case of poisoning.

Nasogastric intubation refers to the insertion of a thin, flexible tube through the nostril, down the back of the throat, and into the stomach. The tube can be used for various purposes, such as draining the stomach of fluids and air or administering nutrients and medications directly into the stomach.

I hope this clarifies any confusion. If you have further questions, please let me know!

Gastrostomy is a surgical procedure that creates an opening through the abdominal wall into the stomach. This opening, called a stoma or gastrostomy tract, allows for the passage of a tube (gastrostomy tube) that can be used to provide enteral nutrition and hydration directly into the stomach when a person is unable to consume food or fluids by mouth due to various medical conditions such as dysphagia, neurological disorders, or head and neck cancers.

Gastrostomy tubes come in different types and sizes, including percutaneous endoscopic gastrostomy (PEG) tubes, laparoscopic gastrostomy tubes, and open surgical gastrostomy tubes. The choice of the procedure depends on various factors such as the patient's medical condition, anatomy, and overall health status.

The primary purpose of a gastrostomy is to ensure adequate nutrition and hydration for individuals who have difficulty swallowing or are unable to consume enough food or fluids by mouth to meet their nutritional needs. It can also help prevent complications associated with prolonged fasting, such as malnutrition, dehydration, and weight loss.

Short Bowel Syndrome (SBS) is a malabsorption disorder that occurs when a significant portion of the small intestine has been removed or is functionally lost due to surgical resection, congenital abnormalities, or other diseases. The condition is characterized by an inability to absorb sufficient nutrients, water, and electrolytes from food, leading to diarrhea, malnutrition, dehydration, and weight loss.

The small intestine plays a crucial role in digestion and absorption of nutrients, and when more than 50% of its length is affected, the body's ability to absorb essential nutrients becomes compromised. The severity of SBS depends on the extent of the remaining small intestine, the presence or absence of the ileocecal valve (a sphincter that separates the small and large intestines), and the functionality of the residual intestinal segments.

Symptoms of Short Bowel Syndrome include:

1. Chronic diarrhea
2. Steatorrhea (fatty stools)
3. Dehydration
4. Weight loss
5. Fat-soluble vitamin deficiencies (A, D, E, and K)
6. Electrolyte imbalances
7. Malnutrition
8. Anemia
9. Bacterial overgrowth in the small intestine
10. Osteoporosis due to calcium and vitamin D deficiencies

Treatment for Short Bowel Syndrome typically involves a combination of nutritional support, medication, and sometimes surgical interventions. Nutritional management includes oral or enteral feeding with specially formulated elemental or semi-elemental diets, as well as parenteral nutrition (intravenous feeding) to provide essential nutrients that cannot be absorbed through the gastrointestinal tract. Medications such as antidiarrheals, H2 blockers, proton pump inhibitors, and antibiotics may also be used to manage symptoms and prevent complications. In some cases, intestinal transplantation might be considered for severe SBS patients who do not respond to other treatments.

Feeding methods refer to the various ways that infants and young children receive nutrition. The most common feeding methods are breastfeeding and bottle-feeding, although some infants may require more specialized feeding methods due to medical conditions or developmental delays.

Breastfeeding is the act of providing human milk to an infant directly from the breast. It is the natural and normal way for infants to receive nutrition and has numerous benefits for both the mother and the baby, including improved immunity, reduced risk of infections, and enhanced bonding between parent and child.

Bottle-feeding involves providing an infant with expressed human milk or formula in a bottle with a rubber nipple. This method can be useful for mothers who are unable to breastfeed due to medical reasons, work commitments, or personal preference. However, it is important to ensure that the bottle and nipple are properly sterilized and that the infant is held in an upright position during feeding to reduce the risk of ear infections and other complications.

For infants who have difficulty breastfeeding or bottle-feeding due to medical conditions such as cleft lip or palate, gastroesophageal reflux disease (GERD), or neurological impairments, specialized feeding methods may be necessary. These may include the use of specially designed bottles, nipples, or feeding tubes that deliver nutrition directly to the stomach or small intestine.

In all cases, it is important to ensure that infants and young children receive adequate nutrition for healthy growth and development. Parents should consult with their healthcare provider to determine the most appropriate feeding method for their child based on their individual needs and circumstances.

A tracheoesophageal fistula (TEF) is an abnormal connection between the trachea (windpipe) and the esophagus (tube that carries food from the mouth to the stomach). This congenital anomaly is usually present at birth and can vary in size and location. It can cause complications such as respiratory distress, feeding difficulties, and recurrent lung infections. TEF is often treated surgically to separate the trachea and esophagus and restore their normal functions.

Hyperemesis Gravidarum is a severe form of nausea and vomiting in pregnancy that is more extreme than the typical morning sickness. It's characterized by persistent vomiting, dehydration, weight loss, and electrolyte imbalance. If left untreated, it can lead to serious complications for both the mother and the baby. The exact cause is not known, but it may be related to high levels of hormones or other substances in the pregnant woman's body. Treatment often involves hospitalization for rehydration, medication to control vomiting, and nutritional support.

The jejunum is the middle section of the small intestine, located between the duodenum and the ileum. It is responsible for the majority of nutrient absorption that occurs in the small intestine, particularly carbohydrates, proteins, and some fats. The jejunum is characterized by its smooth muscle structure, which allows it to contract and mix food with digestive enzymes and absorb nutrients through its extensive network of finger-like projections called villi.

The jejunum is also lined with microvilli, which further increase the surface area available for absorption. Additionally, the jejunum contains numerous lymphatic vessels called lacteals, which help to absorb fats and fat-soluble vitamins into the bloodstream. Overall, the jejunum plays a critical role in the digestion and absorption of nutrients from food.

Esophagectomy is a surgical procedure in which part or all of the esophagus (the muscular tube that connects the throat to the stomach) is removed. This surgery is typically performed as a treatment for esophageal cancer, although it may also be used to treat other conditions such as severe damage to the esophagus from acid reflux or benign tumors.

During an esophagectomy, the surgeon will make incisions in the neck, chest, and/or abdomen to access the esophagus. The affected portion of the esophagus is then removed, and the remaining ends are reconnected, often using a section of the stomach or colon to create a new conduit for food to pass from the throat to the stomach.

Esophagectomy is a complex surgical procedure that requires significant expertise and experience on the part of the surgeon. It carries risks such as bleeding, infection, and complications related to anesthesia. Additionally, patients who undergo esophagectomy may experience difficulty swallowing, chronic pain, and other long-term complications. However, for some patients with esophageal cancer or other serious conditions affecting the esophagus, esophagectomy may be the best available treatment option.

An esophageal fistula is an abnormal connection or passage between the esophagus (the tube that carries food and liquids from the throat to the stomach) and another organ, such as the trachea (windpipe) or the skin. This condition can result from complications of certain medical conditions, including cancer, prolonged infection, or injury to the esophagus.

Esophageal fistulas can cause a variety of symptoms, including difficulty swallowing, coughing, chest pain, and fever. They can also lead to serious complications, such as pneumonia or sepsis, if left untreated. Treatment for an esophageal fistula typically involves surgical repair of the abnormal connection, along with management of any underlying conditions that may have contributed to its development.

Parenteral nutrition (PN) is a medical term used to describe the delivery of nutrients directly into a patient's bloodstream through a vein, bypassing the gastrointestinal tract. It is a specialized medical treatment that is typically used when a patient cannot receive adequate nutrition through enteral feeding, which involves the ingestion and digestion of food through the mouth or a feeding tube.

PN can be used to provide essential nutrients such as carbohydrates, proteins, fats, vitamins, minerals, and electrolytes to patients who have conditions that prevent them from absorbing nutrients through their gut, such as severe gastrointestinal tract disorders, malabsorption syndromes, or short bowel syndrome.

PN is administered through a catheter that is inserted into a vein, typically in the chest or arm. The nutrient solution is prepared under sterile conditions and delivered through an infusion pump to ensure accurate and controlled delivery of the solution.

While PN can be a life-saving intervention for some patients, it also carries risks such as infection, inflammation, and organ damage. Therefore, it should only be prescribed and administered by healthcare professionals with specialized training in this area.

Malabsorption syndromes refer to a group of disorders in which the small intestine is unable to properly absorb nutrients from food, leading to various gastrointestinal and systemic symptoms. This can result from a variety of underlying conditions, including:

1. Mucosal damage: Conditions such as celiac disease, inflammatory bowel disease (IBD), or bacterial overgrowth that cause damage to the lining of the small intestine, impairing nutrient absorption.
2. Pancreatic insufficiency: A lack of digestive enzymes produced by the pancreas can lead to poor breakdown and absorption of fats, proteins, and carbohydrates. Examples include chronic pancreatitis or cystic fibrosis.
3. Bile acid deficiency: Insufficient bile acids, which are necessary for fat emulsification and absorption, can result in steatorrhea (fatty stools) and malabsorption. This may occur due to liver dysfunction, gallbladder removal, or ileal resection.
4. Motility disorders: Abnormalities in small intestine motility can affect nutrient absorption, as seen in conditions like gastroparesis, intestinal pseudo-obstruction, or scleroderma.
5. Structural abnormalities: Congenital or acquired structural defects of the small intestine, such as short bowel syndrome, may lead to malabsorption.
6. Infections: Certain bacterial, viral, or parasitic infections can cause transient malabsorption by damaging the intestinal mucosa or altering gut flora.

Symptoms of malabsorption syndromes may include diarrhea, steatorrhea, bloating, abdominal cramps, weight loss, and nutrient deficiencies. Diagnosis typically involves a combination of clinical evaluation, laboratory tests, radiologic imaging, and sometimes endoscopic procedures to identify the underlying cause. Treatment is focused on addressing the specific etiology and providing supportive care to manage symptoms and prevent complications.

A Gastrectomy is a surgical procedure involving the removal of all or part of the stomach. This procedure can be total (complete resection of the stomach), partial (removal of a portion of the stomach), or sleeve (removal of a portion of the stomach to create a narrow sleeve-shaped pouch).

Gastrectomies are typically performed to treat conditions such as gastric cancer, benign tumors, severe peptic ulcers, and in some cases, for weight loss in individuals with morbid obesity. The type of gastrectomy performed depends on the patient's medical condition and the extent of the disease.

Following a gastrectomy, patients may require adjustments to their diet and lifestyle, as well as potential supplementation of vitamins and minerals that would normally be absorbed in the stomach. In some cases, further reconstructive surgery might be necessary to reestablish gastrointestinal continuity.

Postoperative care refers to the comprehensive medical treatment and nursing attention provided to a patient following a surgical procedure. The goal of postoperative care is to facilitate the patient's recovery, prevent complications, manage pain, ensure proper healing of the incision site, and maintain overall health and well-being until the patient can resume their normal activities.

This type of care includes monitoring vital signs, managing pain through medication or other techniques, ensuring adequate hydration and nutrition, helping the patient with breathing exercises to prevent lung complications, encouraging mobility to prevent blood clots, monitoring for signs of infection or other complications, administering prescribed medications, providing wound care, and educating the patient about postoperative care instructions.

The duration of postoperative care can vary depending on the type and complexity of the surgical procedure, as well as the individual patient's needs and overall health status. It may be provided in a hospital setting, an outpatient surgery center, or in the patient's home, depending on the level of care required.

The Witzel jejunostomy is the most common method of jejunostomy creation. It is an open technique where the jejunosotomy is ... Jejunostomy is the surgical creation of an opening (stoma) through the skin at the front of the abdomen and the wall of the ... A jejunostomy may be formed following bowel resection in cases where there is a need to bypass the distal small bowel and/or ... A jejunostomy is different from a jejunal feeding tube. A jejunal feeding tube is an alternative to a gastrostomy feeding tube ...
Sherren, James (1925). "Bradshaw Lecture ON GASTRO-JEJUNOSTOMY". The Lancet. 206 (5333): 1007-1017. doi:10.1016/S0140-6736(01) ...
Leaks usually occur at the stomach-intestine connection (gastro-jejunostomy). As the anastomosis heals, it forms scar tissue, ...
These may be used for feed (e.g. gastrostomy and jejunostomy) or to flush the intestines. Colostomy or ileostomy can bypass ... The stoma may be a gastrostomy, jejunostomy, ileostomy or cecostomy. ...
Tube placement may also be done by percutaneous endoscopic gastrostomy, or surgical jejunostomy. In patients whose intestinal ...
... oral glucose in the reduction of jejunostomy effluent and gluten subfractions in coeliac disease. In 1976 Hawkins and ...
Medical device French catheter scale Gastrostomy G-Tube Jejunostomy Stent Curran, Evonne (September 2016). "Needleless ...
A gastronomy or jejunostomy feeding tube may be placed before the abdominal wall is closed. When a liver is being transplanted ...
Radiologically inserted gastrostomy or jejunostomy : Placement of a feeding tube percutaneously into the stomach and/or jejunum ...
A jejunostomy feeding tube (J-tube) is a tube surgically or endoscopically inserted through the abdomen and into the jejunum ( ... Wang, L; Tian, Z; Liu, Y (January 2017). "Nasoenteric tube versus jejunostomy for enteral nutrition feeding following major ... or jejunostomy feeding tube. A nasogastric feeding tube or NG-tube is passed through the nares (nostril), down the esophagus ... as torture Nutrient enema Nasogastric tube Medical food Intralipid Gastrostomy Percutaneous endoscopic gastrostomy Jejunostomy ...
... treatment for relief of obstruction usually is bypassing the obstructed segment of duodenum by duodeno-jejunostomy. In adults, ...
Cannula Foley catheter French catheter scale Gastrostomy G-Tube Jejunostomy Stent "catheter noun - Definition, pictures, ...
... jejunostomy, and transanastomotic silicone stent". Journal of Pediatric Surgery. 38 (8): 1250-1252. doi:10.1016/S0022-3468(03) ... jejunostomy, and transanastomotic silicone stent". Journal of Pediatric Surgery. 38 (8): 1250-1252. doi:10.1016/S0022-3468(03) ...
... a gastrostomy or jejunostomy) due to difficulties with chewing and swallowing.[medical citation needed] Various medications can ...
... or jejunostomy. A 2018 Cochrane review found no certain evidence about the immediate and long-term effects of modifying the ...
... or if oral intake is not adequate through a jejunostomy feeding tube. Treatment includes dietary modifications, medications to ...
Enteral feeding via a tube (nasogastric tube, PEG or jejunostomy) is commonly used in the treatment of premature infants and ... gastrostomy or jejunostomy tube. The treatment is performed either when the feeding tube is no longer needed or if children ...
Gastrostomy Percutaneous endoscopic gastrostomy Gastroduodenostomy Gastroenterostomy Ileostomy Jejunostomy Colostomy ...
... "gastro-jejunostomy") and attaching a loop of jejunum to the cystic duct to drain bile ("cholecysto-jejunostomy"). It can be ...
Cecostomy Colostomy Duodenostomy Ileostomy Jejunostomy Appendicostomy (see also continence appendicostomy) One well-known form ...
eMedicine: Percutaneous Gastrostomy and Jejunostomy (Articles with short description, Short description matches Wikidata, All ...
... jejunostomy MeSH E04.579.358 - esophagostomy MeSH E04.579.408 - gastrostomy MeSH E04.579.592 - middle ear ventilation MeSH ... jejunostomy MeSH E04.210.346 - esophagectomy MeSH E04.210.355 - esophagoplasty MeSH E04.210.358 - esophagostomy MeSH E04.210. ...
... the first robotic hepatico-jejunostomy in India and the first low anterior resection in North India. Reports also credit him ...
Roux-en-Y hepatico jejuno stomy used to treat (macroscopic) bile duct obstruction which may arise due to: a common bile duct ...
The Witzel jejunostomy is the most common method of jejunostomy creation. It is an open technique where the jejunosotomy is ... Jejunostomy is the surgical creation of an opening (stoma) through the skin at the front of the abdomen and the wall of the ... A jejunostomy may be formed following bowel resection in cases where there is a need to bypass the distal small bowel and/or ... A jejunostomy is different from a jejunal feeding tube. A jejunal feeding tube is an alternative to a gastrostomy feeding tube ...
Octreotide improves fluid balance in patients who have undergone jejunostomy but reduces the use of amino acids for splanchnic ... Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies Gastroenterology. 1994 Aug;107( ... Background/aims: Previous studies have shown that secretory losses in patients with end jejunostomy syndrome (EJS) on home ... Conclusions: Octreotide improves fluid balance in patients who have undergone jejunostomy but reduces the use of amino acids ...
Direct percutaneous endoscopic jejunostomy (PEJ) is a viable alternative to operative jejunostomy tube placement. ... Percutaneous Endoscopic Jejunostomy Tube: Large Single Institution Experience and 30-Day Outcomes. Andrew T Strong, MD, Gautam ... direct PEJ offers a less invasive alternative to operative jejunostomy tube. Direct PEJ can be placed in the endoscopy suite or ...
MILA Jejunostomy Tube 10fr x 90cm. £109.99. Each Add to basket. * MILA Jejunostomy Tube 6fr x 90cm. £109.99. Each Add to basket ... MILA Jejunostomy Tube 10fr x 108cm. £79.99. Each Add to basket. * ... MILA Jejunostomy Tube 8fr x 90cm. £109.99. Each Add to basket. 30 products per page. 60 products per page. All products per ... Explore our Jejunostomy products and discover the perfect equipment to enhance your veterinary practice. ...
The Radiology Department at Cincinnati Childrens is a leader in pediatric diagnostic imaging, radiology research, and radiation dose reduction. ...
Jejunostomy Threaded Connector Caps are specifically used with jejunostomy feeding tubes. These threaded connector caps have ... Decrease quantity for MIC* Jejunostomy Threaded Connector Caps Increase quantity for MIC* Jejunostomy Threaded Connector Caps ... MIC* Jejunostomy Threaded Connector Caps are specifically used with jejunostomy feeding tubes. ...
Re: Mercury radioactive extreme reaches expectations astonishing jejunostomy. « Reply #1 on: 14 October 2023, 11:54:25 » ... Mercury radioactive extreme reaches expectations astonishing jejunostomy. « on: 06 December 2022, 10:18:40 » ... Author Topic: Mercury radioactive extreme reaches expectations astonishing jejunostomy. (Read 5 times) ... Mercury radioactive extreme reaches expectations astonishing jejunostomy. ...
The Halyard Health MIC* Jejunostomy Feeding Tube is indicated for patients requiring jejunal feeding. It is surgically placed ...
Jejunostomy tubes are a form of enteral nutrition used in patients following a diagnosis of oesophageal or gastric cancer. ... Olusona O,. Reducing Hospital Visits for Patients with Jejunostomy Tubes [MSc Thesis]. Dublin: Royal College of Surgeons in ... the number of hospital visits in patients with jejunostomy tubes. This was achieved by using the DMAIC framework as a guide ...
Paracetamol absorption from a feeding jejunostomy. / Nelson, E. B.; Abernethy, D. R.; Greenblatt, D. J. et al. In: British ... Nelson EB, Abernethy DR, Greenblatt DJ, Ameer B. Paracetamol absorption from a feeding jejunostomy. British Journal of Clinical ... Nelson, E. B., Abernethy, D. R., Greenblatt, D. J., & Ameer, B. (1986). Paracetamol absorption from a feeding jejunostomy. ... Paracetamol absorption from a feeding jejunostomy. In: British Journal of Clinical Pharmacology. 1986 ; Vol. 22, No. 1. pp. 111 ...
Jejunostomy is the recommended route for enteral nutrition in certain patients. Various methods and equipment had been proposed ... With the above two maneuvers, totally laparoscopic feeding jejunostomy could be completed with one 11mm trocar plus two 5mm ... Most patients started feeding via the jejunostomy tube within 3 days following the operation (58/69, 84%), and none of them ... Allen JW, Ali A, Wo J, Bumpous JM, Cacchione RN (2002) Totally laparoscopic feeding jejunostomy. Surg Endosc 16(12):1802-1805. ...
Jejunostomy tube (J-tube) is a soft tube placed through the skin, into the small intestine and is used to deliver food and ... What is a Jejunostomy tube?. Jejunostomy tube (J-tube) is a soft tube placed through the skin, into the small intestine and is ... Jejunostomy (J-Tube) Procedure. While you or a loved one is asleep under general anesthesia, a surgeon surgically places the J- ... How to Clean and Dress a Jejunostomy Tube. To keep the skin around the J-tube clean and dry, youll need to change the bandages ...
Brand MIC Disposable/Reusable/Reposable Single Use Item Adapter Item Type Jejunostomy Feeding Port Material Silicone Primary ... Adapter Jejunostomy Feeding Port MIC 9fr Non-Sterile 5/Ca. $93.99 $114.99 ... Hi! I need next info about the "Adapter Jejunostomy Feeding Port MIC 9fr Non-Sterile 5/Ca":. ... I am waiting for this item "Adapter Jejunostomy Feeding Port MIC 9fr Non-Sterile 5/Ca" ...
Freka Surgical Jejunostomy Set * Freka EasyIn Double Lumen Nasojejunal Feeding Tube * Freka Endolumina Single Lumen Nasojejunal ...
Gastrostomy and jejunostomy. In: Mauro MA, Murphy KP, Thomson KR, Venbrux AC, Morgan RA, eds. Image-Guided Interventions. 3rd ...
Jejunostomy for intractable gastroparesis. * Implantation of a penile prosthesis for ongoing impotence ...
Outcomes comparison of Pancreato-Gastrostomy and Isolated Jejunal Loop Pancreato-Jejunostomy following Pancreato-Duodenectomy ... versus Isolated Jejunal Loop Pancreato-Jejunostomy (IJL-PJ). 193 patients with a Callery Fistula Risk Score (C-FRS) ≥ 3 ... versus Isolated Jejunal Loop Pancreato-Jejunostomy (IJL-PJ). 193 patients with a Callery Fistula Risk Score (C-FRS) ≥ 3 ... Outcomes comparison of Pancreato-Gastrostomy and Isolated Jejunal Loop Pancreato-Jejunostomy following Pancreato-Duodenectomy ...
Patients of BOFJ had greater preoperative body mass, shorter distance between jejunostomy and midline, and greater ... Patients with BOFJ had shorter distance between the jejunostomy and midline (40 mm versus 48 mm, P = 0.011) compared to ... and shorter distance between the jejunostomy and midline (OR = 8.160; 95% CI = 1.675-39.747, p = 0.009) were independently ... Our aim was to clarify the incidence of bowel obstruction associated with a feeding jejunostomy (BOFJ) after thoracoscopic ...
Laparoscopic Jejunostomy. *Laparoscopic Lysis Of Peritoneal Adhesions. *Laparoscopic Rectal Prolapse Repair. *Laparoscopic ...
Jejunostomy feeding. Bypass the pancreas. - General anesthetic mandatory. - Delicate tube placement. - Intensive care required ...
... jejunostomy; antrectomy (resection of pyloric antrum of stomach) 40 Partial2/subtotal/hemigastrectomy, NOS; resection of ...
gastrostomy - jejunostomy - advanced technique Publication History. Received: 04 June 2023. Accepted: 17 June 2023. Article ... Direct percutaneous jejunostomy: techniques and applications -- ten years experience. Radiology 1998; 209 (03) 747-754 ... US and fluoroscopic-guided percutaneous jejunostomy: experience in 49 patients. J Vasc Interv Radiol 2000; 11 (01) 101-106 ... Percutaneous replacement jejunostomy after esophagogastrectomy. J Gastrointest Surg 2000; 4 (04) 407-410 ...
Examples include a gastrostomy or a jejunostomy. A few very specialized procedures create new internal structures using ...
Radiologists use image-guided care to treat you with the most appropriate, least invasive treatments available.
I am Alexandra C. Koch, DNP, APNP, AGPCNP-BC, CWON-AP, a specialist with the Froedtert & MCW health network. I specialize in ostomy. I practice at Wound Healing Program - Froedtert.
Only one patient required double bypass (hepatico-jejunostomy + gastro-jejunostomy) due to tumor infiltration of the duodenum. ... Gastro-jejunostomy was performed in patients who had a high risk for duodenal obstruction during the survival period, such as ... In the surgery group 16 patients underwent choledocho-duodenostomy and 5 patients a roux-en-Y hepatico-je- junostomy for ... A bypass comprises hepatico-duodenostomy or an end-to-side Rou- en-Y hepatico-jejunostomy after gallbladder removal. ...
Gastrostomy/Jejunostomy Tube Care. *Glucometer/Blood Glucose Meter. *Infinity Pump. *Injections: Intramuscular/Subcutaneous ...
Jejunostomy tube (J-tube). A J-tube is placed into the upper part of the intestine (jejunum), just beyond the stomach. The tube ...
Chemoembolization, Transjugular intrahepatic portosystemic shunt, Jejunostomy, Gastrostomy, Uterine artery embolization..., ...

No FAQ available that match "jejunostomy"

No images available that match "jejunostomy"